Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Oct;78(1):108–114.

Precipitation of experimental autoallergic uveoretinitis by cyclosporin A withdrawal: an experimental model of uveitis relapse.

E G Atkinson 1, W J Dinning 1, E Kasp 1, E M Graham 1, D C Dumonde 1
PMCID: PMC1534608  PMID: 2805414

Abstract

This study set out to determine whether withdrawal of cyclosporin A (CyA) in Lewis rats sensitized to retinal S antigen would precipitate experimental autoallergic uveoretinitis (EAU), and whether challenge of such animals with S antigen or an unrelated stimulus would accelerate EAU onset after drug withdrawal. Rats were sensitized with 50 micrograms S antigen in Freund's complete adjuvant (FCA) and EAU onset was suppressed by 18 days of treatment with CyA at doses ranging from 3 to 10 mg/kg daily. Without challenge, seven out of 11 animals developed EAU with a median onset of 78 days. This was reduced to 68 days in rats challenged on day 32 with FCA alone, to 48 days with 10 micrograms S antigen in FCA, and to 41 days with 50 micrograms S antigen in FCA. The incidence, onset and severity of anterior uveitis and extent of photoreceptor destruction were related to both CyA dose and nature of challenge. The extent of photoreceptor destruction ran parallel with severity of anterior uveitis; and delayed-type hypersensitivity reactivity on day 43 was related to both severity of anterior uveitis (P less than 0.001) and photoreceptor damage (P less than 0.002). At the highest dose, CyA also delayed the appearance of antibody to S antigen; however, subsequent antibody levels were unrelated to EAU severity or to nature of challenge. The results indicate that CyA-induced suppression of the immunological response to S antigen can recover spontaneously after drug withdrawal, that challenge with either S antigen or FCA alone can accelerate the subsequent onset of EAU, and that these phenomena may provide a basis for investigating mechanisms underlying relapse of human uveoretinitis.

Full text

PDF
108

Images in this article

113Fig. 5
on p.113

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Byars N. E. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J Immunol Methods. 1986 Dec 24;95(2):157–168. doi: 10.1016/0022-1759(86)90402-3. [DOI] [PubMed] [Google Scholar]
  2. Benezra D., Cohen E. Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol. 1986 Aug;70(8):589–592. doi: 10.1136/bjo.70.8.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Binder A. I., Graham E. M., Sanders M. D., Dinning W., James D. G., Denman A. M. Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol. 1987 Aug;26(4):285–291. doi: 10.1093/rheumatology/26.4.285. [DOI] [PubMed] [Google Scholar]
  4. Brown E. C., Kasp E., Dumonde D. C. Morphometric analysis of T lymphocyte compartmentation in experimental autoimmune uveoretinitis. Clin Exp Immunol. 1989 Sep;77(3):422–427. [PMC free article] [PubMed] [Google Scholar]
  5. Caspi R. R., McAllister C. G., Gery I., Nussenblatt R. B. Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis. Cell Immunol. 1988 May;113(2):350–360. doi: 10.1016/0008-8749(88)90033-0. [DOI] [PubMed] [Google Scholar]
  6. Chan C. C., Caspi R., Mochizuki M., Diamantstein T., Gery I., Nussenblatt R. B. Cyclosporine and dexamethasone inhibit T-lymphocyte MHC class II antigens and IL-2 receptor expression in experimental autoimmune uveitis. Immunol Invest. 1987 Jun;16(4):319–331. doi: 10.3109/08820138709087087. [DOI] [PubMed] [Google Scholar]
  7. Chan C. C., Palestine A. G., Nussenblatt R. B. Cyclosporine-induced alterations of humoral response in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 1984 Jul;25(7):867–870. [PubMed] [Google Scholar]
  8. Graham E. M., Sanders M. D., James D. G., Hamblin A., Kasp Grochowska E., Dumonde D. Cyclosporin A in the treatment of posterior uveitis. Trans Ophthalmol Soc U K. 1985;104(Pt 2):146–151. [PubMed] [Google Scholar]
  9. Hess A. D., Esa A. H., Colombani P. M. Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation. Transplant Proc. 1988 Apr;20(2 Suppl 2):29–40. [PubMed] [Google Scholar]
  10. Kasp E., Banga J. P., Brown E. C., Wicking J. M., Suleyman S., Ellis B. A., Sanders M. D., Dumonde D. C. An improved method for the purification of retinal S-antigen using selective hydrophobic adsorption chromatography. J Immunol Methods. 1987 Jun 26;100(1-2):147–152. doi: 10.1016/0022-1759(87)90183-9. [DOI] [PubMed] [Google Scholar]
  11. Liversidge J., Thomson A. W., Sewell H. F., Forrester J. V. EAU in the guinea pig: inhibition of cell-mediated immunity and Ia antigen expression by cyclosporin A. Clin Exp Immunol. 1987 Sep;69(3):591–600. [PMC free article] [PubMed] [Google Scholar]
  12. Mochizuki M., Nussenblatt R. B., Kuwabara T., Gery I. Effects of cyclosporine and other immunosuppressive drugs on experimental autoimmune uveoretinitis in rats. Invest Ophthalmol Vis Sci. 1985 Feb;26(2):226–232. [PubMed] [Google Scholar]
  13. Nussenblatt R. B. Basic and clinical immunology in uveitis. Jpn J Ophthalmol. 1987;31(3):368–374. [PubMed] [Google Scholar]
  14. Nussenblatt R. B., Rodrigues M. M., Wacker W. B., Cevario S. J., Salinas-Carmona M. C., Gery I. Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest. 1981 Apr;67(4):1228–1231. doi: 10.1172/JCI110138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Palestine A. G., Roberge F., Charous B. L., Lane H. C., Fauci A. S., Nussenblatt R. B. The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans. J Clin Immunol. 1985 Mar;5(2):115–121. doi: 10.1007/BF00915009. [DOI] [PubMed] [Google Scholar]
  16. Stanford M. R., Atkinson E., Kasp E., Dumonde D. C. Modulation of experimental retinal vasculitis using dexamethasone, cyclosporin A, and prazosin. Eye (Lond) 1987;1(Pt 5):626–631. doi: 10.1038/eye.1987.97. [DOI] [PubMed] [Google Scholar]
  17. Zaal J., Doekes G., Breebaart A. C., Kijlstra A. Quantitative determination of S-antigen in human ocular tissues, aqueous humour and serum. Curr Eye Res. 1986 Oct;5(10):763–775. doi: 10.3109/02713688609000018. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES